Inhibition of Vascular Endothelial Growth Factor Receptor 3 Reduces Migration of Gastric Cancer Cells

Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A

(2015) Esak Lee et al.   NEOPLASIA

Cellular Migration and Invasion Uncoupled: Increased Migration Is Not an Inexorable Consequence of Epithelial-to-Mesenchymal Transition

(2014) D. Schaeffer et al.   MOLECULAR AND CELLULAR BIOLOGY

The Indolinone MAZ51 Induces Cell Rounding and G2/M Cell Cycle Arrest in Glioma Cells without the Inhibition of VEGFR-3 Phosphorylation: Involvement of the RhoA and Akt/GSK3β Signaling Pathways

(2014) Joo-Hee Park et al.   PLoS One

Treatment options in patients with metastatic gastric cancer: Current status and future perspectives

(2014) Ahmet Bilici   WORLD JOURNAL OF GASTROENTEROLOGY

VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2

(2014) Jaeyoung Lim et al.   NEOPLASIA

VEGF-C and VEGF-D Blockade Inhibits Inflammatory Skin Carcinogenesis

(2013) A. K. Alitalo et al.   CANCER RESEARCH

A VEGFR-3 Antagonist Increases IFN-γ Expression on Low Functioning NK Cells in Acute Myeloid Leukemia

(2013) Ji Yoon Lee et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Inhibition of angiogenesis by a novel neutralizing antibody targeting human VEGFR-3

(2013) Hao Chen et al.   mAbs

The Role of the VEGF-C/VEGFRs Axis in Tumor Progression and Therapy

(2012) Jui-Chieh Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

SAR131675, a Potent and Selective VEGFR-3-TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities

(2012) A. Alam et al.   MOLECULAR CANCER THERAPEUTICS

Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+channel

(2011) G.-W. Lee et al.   Acta Physiologica

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer

(2011) Hanseul Yang et al.   Molecular Cancer

Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms

(2011) N Khromova et al.   ONCOGENE

Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases

(2010) Xiao-Lei Wang et al.   BMC CANCER

The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma

(2010) F.-H. Han et al.   EJSO

Autocrine Loop between Vascular Endothelial Growth Factor (VEGF)-C and VEGF Receptor-3 Positively Regulates Tumor-Associated Lymphangiogenesis in Oral Squamoid Cancer Cells

(2009) Masaki Matsuura et al.   AMERICAN JOURNAL OF PATHOLOGY

Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model

(2009) M Yashiro et al.   BRITISH JOURNAL OF CANCER

Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles

(2008) A. Ny et al.   BLOOD

Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells

(2008) C.-I. Lin et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms

(2008) M. Kodama et al.   CLINICAL CANCER RESEARCH

Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice

(2008) Hanna Sallinen et al.   MOLECULAR THERAPY